"This action is not anticipated to disrupt the overall supply for these products, as alternative manufacturers supplying the Canadian market are not affected," a spokesperson for the department said.Health Canada said it was informed by the European Directorate for Quality of Medicines & Health Care about the European agency's recent inspection of Smruthi Organics Limited of India, where the active pharmaceutical ingredients used in the manufacturing of the recalled products were sourced.The department said more information will be publicly available after the European agency releases its final inspection reports.For more information, people can contact Health Canada toll free at 1-866-225-0709.It is a priority for CBC to create a website that is accessible to all Canadians including people with visual, hearing, motor and cognitive challenges.Closed Captioning and Described Video is available for many CBC shows offered onFour companies have announced the recall of several batches of prescription drugs on the Canadian market.Recall issued for 5 prescription drugs sold in Canada CO Amlodipine by Meliapharm is no longer being manufactured for sale in Canada. "This action is not anticipated to disrupt the overall supply for these products, as alternative manufacturers supplying the Canadian market are not affected," a spokesperson for the department said.Health Canada said it was informed by the European Directorate for Quality of Medicines & Health Care about the European agency's recent inspection of Smruthi Organics Limited of India, where the active pharmaceutical ingredients used in the manufacturing of the recalled products were sourced.The department said more information will be publicly available after the European agency releases its final inspection reports.For more information, people can contact Health Canada toll free at 1-866-225-0709.It is a priority for CBC to create a website that is accessible to all Canadians including people with visual, hearing, motor and cognitive challenges.Closed Captioning and Described Video is available for many CBC shows offered onFour companies have announced the recall of several batches of prescription drugs on the Canadian market.Recall issued for 5 prescription drugs sold in Canada 1) Amlodipine is bad for your heart. I do not think either of these medications are actually banned in Holland or Canada, it is due to a massive recall. "The U.S. Food and Drug Administration (FDA) expanded its recall of a common … Sign up now. With valsartan and losartan recently recalled due to contamination, patients have been asking about other options for blood pressure control. Starting date: March 29, 2017 Posting date: April 10, 2017 Type of communication: Drug Recall Subcategory: Drugs Hazard classification: Type II Source of recall: Health Canada Issue: Product Safety Audience: General Public, Healthcare Professionals, Hospitals Identification number: RA-62952. Amlodipine, sold under the brand name Norvasc among others, is a medication used to treat high blood pressure and coronary artery disease. © 1998-2020 Mayo Foundation for Medical Education and Research (MFMER). Though both amlodipine treatments more effectively reduced daytime blood pressure levels, the circadian profile was not greatly affected. After taking a dose of this medicine you may get a headache that lasts for a short time. While not typically recommended in heart failure, amlodipine may be used if other medications are not sufficient for treating high blood pressure or heart-related chest pain. Amlodipine often gets a bad rap, but as you’ll see, the best meds can be those that have been used for decades. Data sources include IBM Watson Micromedex (updated 2 Sep 2020), Cerner Multum™ (updated 1 Sep 2020), … Reason Depth of distribution Affected … Check with your doctor for the best way to reduce gradually the amount you are taking before stopping completely. Advertising revenue supports our not-for-profit mission.Check out these best-sellers and special offers on books and newsletters from Mayo Clinic. Four companies have announced the recall of several batches of prescription drugs in use in Canada.Health Canada said it has not received any reports of adverse effects related to the medications, and the recall is a precautionary measure.A statement released this morning said the decision was made after the four companies — Cobalt Pharmaceuticals, Laboratoire Riva, Mylan Pharmaceuticals and Sanis Health — consulted with Health Canada.Patients taking any of the listed drugs are advised not to discontinue their treatment until first consulting with their physician.Cobalt Pharmaceuticals noted the recall covers particular lots of its norfloxacin and telmisartan products only.Mylan Pharmaceuticals' recalled products included particular doses and lot numbers of lamotrigine, amlodipine and ciprofloxacin.Sanis Health's recalled products were certain doses and lot numbers of lamotrigine and amlodipine.Laboratoire Riva's recall was for two lots of its 500-milligram ciprofloxacin.In an email to CBC News, Health Canada said the issues are mainly related to processes that affect quality control and oversight.